Expression of FKBP52 in the ovaries of PCOS rats

Song,Shiyan; Tan,Yong

doi:10.3892/ijmm.2018.3998

Expression of FKBP52 in the ovaries of PCOS rats

Authors:
- Shiyan Song
- Yong Tan
View Affiliations

Affiliations: Nanjing University of Chinese Medicine, Nanjing, Jiangsu 210029, P.R. China, Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, Jiangsu 210029, P.R. China
Published online on: November 26, 2018 https://doi.org/10.3892/ijmm.2018.3998
Pages: 868-878
Copyright: © Song et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The present study aimed to examine the expression of FK‑506 binding protein 52 (FKBP52) in the ovary tissues of rats with polycystic ovarian syndrome (PCOS) and its action on mediating androgen receptor (AR) through the mitogen‑activated protein kinase (MAPK)/extracellular signal‑regulated kinase (ERK) pathway. PCOS model rats were established by dehydroepiandrosterone injection. Enzyme‑linked immunosorbent assay (ELISA) measured serum sex hormones. Hematoxylin and eosin (H&E) staining was used to examine histological changes of the ovarian tissues. The expression levels of FKBP52 were detected by immunohistochemical (IHC) staining, reverse transcription‑quantitative polymerase chain reaction (RT‑qPCR) analysis and western blotting (WB). In addition, RT‑qPCR analysis was used to detect the mRNA expression of AR, and WB was used to detect the protein expression levels of AR, ERK1/2 and phosphorylated (p‑)ERK1/2. In granulosa cell (GC) experiments, primary GCs were extracted and cultured. FKBP4 is the FKBP52‑encoding gene, therefore, adenovirus vectors Ad‑Oe‑FKBP4‑EGFP and Ad‑siRNA‑FKBP4‑EGFP were constructed to examine the association among the above factors using the RT‑qPCR and WB methods. In the animal experiment, the vaginal smear, H&E staining and ELISA results showed that the PCOS model was successfully established. The IHC staining revealed that the expression of FKBP52 in the GCs of the PCOS model group was higher than the remaining groups (P<0.01). The mRNA and expression levels of FKBP52 and AR in the PCOS model rats were significantly increased, when compared with levels in the other rats (P<0.05). The expression level of p‑ERK1/2 was also higher (P<0.05). In the GC experiment, following overexpression of the FKBP4 gene, the mRNA and expression levels of FKBP52 and AR were increased (P<0.05). The expression level of p‑ERK1/2 was also increased (P<0.05). Following FKBP4 gene silencing, the mRNA and expression levels of FKBP52 and AR were decreased (P<0.05). The expression level of ERK1/2 was also decreased (P<0.05). However, the expression level of p‑ERK1/2 was increased (P<0.05). In conclusion, the upregulation of co‑chaperone FKBP52 may mediate the activation of AR through the MAPK/ERK pathway.

View Figures

View References

1	Chiofalo B, Laganà AS, Palmara V, Granese R, Corrado G, Mancini E, Vitale SG, Ban Frangež H, Vrtačnik-Bokal E and Triolo O: Fasting as possible complementary approach for poly-cystic ovary syndrome: Hope or hype. Med Hypotheses. 105:1–3. 2017. View Article : Google Scholar : PubMed/NCBI
2	Asemi Z, Samimi M, Taghizadeh M and Esmaillzadeh A: Effects of Ramadan fasting on glucose homeostasis, lipid profiles, inflammation and oxidative stress in women with polycystic ovary syndrome in Kashan, Iran. Arch Iran Med. 18:806–810. 2015.PubMed/NCBI
3	Franks S: Controversy in clinical endocrinology: Diagnosis of polycystic ovarian syndrome: In defense of the rotterdam criteria. J Clin Endocrinol Metab. 91:786–789. 2006. View Article : Google Scholar : PubMed/NCBI
4	Qu J, Wang Y, Wu X, Gao L, Hou L and Erkkola R: Insulin resistance directly contributes to androgenic potential within ovarian theca cells. Fertil Steril. 91:1990–1997. 2009. View Article : Google Scholar
5	Laganà AS and Pizzo A: Authors’ reply to: ‘Empiric’ inositol supplementation in normal-weight non-insulin resistant women with polycystic ovarian disease: From the absence of benefit to the potential adverse effects. Arch Gynecol Obstet. 291:959–960. 2015. View Article : Google Scholar
6	Wang FF, Pan JX, Wu Y, Zhu YH, Hardiman PJ and Qu F: American, European, and Chinese practice guidelines or consensuses of poly-cystic ovary syndrome: A comparative analysis. J Zhejiang Univ Sci B. 19:354–363. 2018. View Article : Google Scholar : PubMed/NCBI
7	Tai PK, Maeda Y, Nakao K, Wakim NG, Duhring JL and Faber LE: A 59-kilodalton protein associated with progestin, estrogen, androgen, and glucocorticoid receptors. Biochemistry. 25:5269–5275. 1986. View Article : Google Scholar : PubMed/NCBI
8	Davies TH and Sánchez ER: FKBP52. Int J Biochem Cell Biol. 37:42–47. 2005. View Article : Google Scholar
9	Cheung-Flynn J, Prapapanich V, Cox MB, Riggs DL, Suarez- Quian C and Smith DF: Physiological role for the cochaperone FKBP52 in androgen receptor signaling. Mol Endocrinol. 19:1654–1666. 2005. View Article : Google Scholar : PubMed/NCBI
10	Periyasamy S, Warrier M, Tillekeratne MP, Shou W and Sanchez ER: The immunophilin ligands cyclosporin A and FK506 suppress prostate cancer cell growth by androgen receptor-dependent and -independent mechanisms. Endocrinology. 148:4716–4726. 2007. View Article : Google Scholar : PubMed/NCBI
11	Lin JF, Xu J, Tian HY, Gao X, Chen QX, Gu Q, Xu GJ, Song JD and Zhao FK: Identification of candidate prostate cancer biomarkers in prostate needle biopsy specimens using proteomic analysis. Int J Cancer. 121:2596–2605. 2007. View Article : Google Scholar : PubMed/NCBI
12	De Leon JT, Iwai A, Feau C, Garcia Y, Balsiger HA, Storer CL, Suro RM, Garza KM, Lee S, Kim YS, et al: Targeting the regulation of androgen receptor signaling by the heat shock protein 90 cochaperone FKBP52 in prostate cancer cells. Proc Natl Acad Sci USA. 108:11878–11883. 2011. View Article : Google Scholar : PubMed/NCBI
13	Yong W, Yang Z, Periyasamy S, Chen H, Yucel S, Li W, Lin LY, Wolf IM, Cohn MJ, Baskin LS, et al: Essential role for Co-chaperone FKBP52 but not FKBP51 in androgen receptor-mediated signaling and physiology. J Biol Chem. 282:5026–5036. 2007. View Article : Google Scholar
14	Ketefian A, Jones MR, Krauss RM, Chen YD, Legro RS, Azziz R and Goodarzi MO: Association study of androgen signaling pathway genes in polycystic ovary syndrome. Fertil Steril. 105:467–473. e42016. View Article : Google Scholar :
15	McCubrey JA, Steelman LS, Chappell WH, Abrams SL, Wong EW, Chang F, Lehmann B, Terrian DM, Milella M, Tafuri A, et al: Roles of the Raf/MEK/ERK pathway in cell growth, malignant transformation and drug resistance. Biochim Biophys Acta. 1773:1263–1284. 2007. View Article : Google Scholar
16	Roberts PJ and Der CJ: Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer. Oncogene. 26:3291–3310. 2007. View Article : Google Scholar : PubMed/NCBI
17	Peterziel H, Mink S, Schonert A, Becker M, Klocker H and Cato AC: Rapid signalling by androgen receptor in prostate cancer cells. Oncogene. 18:6322–6329. 1999. View Article : Google Scholar : PubMed/NCBI
18	Belani M, Deo A, Shah P, Banker M, Singal P and Gupta S: Differential insulin and steroidogenic signaling in insulin resistant and non-insulin resistant human luteinized granulosa cells-A study in PCOS patients. J Steroid Biochem Mol Biol. 178:283–292. 2018. View Article : Google Scholar : PubMed/NCBI
19	Miao ZL, Guo L, Wang YX, Cui R, Yang N, Huang MQ, Qin WB, Chen J, Li HM, Wang ZN and Wei XC: The intervention effect of Rosiglitozone in ovarian fibrosis of PCOS rats. Biomed Environ Sci. 25:46–52. 2012.PubMed/NCBI
20	Anderson E, Lee GY and O’Brien K: Polycystic ovarian condition in the dehydroepiandrosterone-treated rat model: Hyperandrogenism and the resumption of meiosis are major initial events associated with cystogenesis of antral follicles. Anat Rec. 249:44–53. 1997. View Article : Google Scholar : PubMed/NCBI
21	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar
22	Hong J, Kim ST, Tranguch S, Smith DF and Dey SK: Deficiency of co-chaperone immunophilin FKBP52 compromises sperm fertilizing capacity. Reproduction. 133:395–403. 2007. View Article : Google Scholar : PubMed/NCBI
23	Tranguch S, Cheung-Flynn J, Daikoku T, Prapapanich V, Cox MB, Xie H, Wang H, Das SK, Smith DF and Dey SK: Cochaperone immunophilin FKBP52 is critical to uterine receptivity for embryo implantation. Proc Natl Acad Sci USA. 102:14326–14331. 2005. View Article : Google Scholar : PubMed/NCBI
24	Tranguch S, Wang H, Daikoku T, Xie H, Smith DF and Dey SK: FKBP52 deficiency-conferred uterine progesterone resistance is genetic background and pregnancy stage specific. J Clin Invest. 117:1824–1834. 2007. View Article : Google Scholar : PubMed/NCBI
25	Yang Z, Wolf IM, Chen H, Periyasamy S, Chen Z, Yong W, Shi S, Zhao W, Xu J, Srivastava A, et al: FK506-binding protein 52 is essential to uterine reproductive physiology controlled by the progesterone receptor A isoform. Mol Endocrinol. 20:2682–2694. 2006. View Article : Google Scholar : PubMed/NCBI
26	Hirota Y, Tranguch S, Daikoku T, Hasegawa A, Osuga Y, Taketani Y and Dey SK: Deficiency of immunophilin FKBP52 promotes endometriosis. Am J Pathol. 173:1747–1757. 2008. View Article : Google Scholar : PubMed/NCBI
27	Caldwell AS, Eid S, Kay CR, Jimenez M, McMahon AC, Desai R, Allan CM, Smith JT, Handelsman DJ and Walters KA: Haplosufficient genomic androgen receptor signaling is adequate to protect female mice from induction of polycystic ovary syndrome features by prenatal hyperandrogenization. Endocrinology. 156:1441–1452. 2015. View Article : Google Scholar : PubMed/NCBI
28	Walters KA: Role of androgens in normal and pathological ovarian function. Reproduction. 149:R193–R218. 2015. View Article : Google Scholar
29	Caldwell ASL, Edwards MC, Desai R, Jimenez M, Gilchrist RB, Handelsman DJ and Walters KA: Neuroendocrine androgen action is a key extraovarian mediator in the development of polycystic ovary syndrome. Proc Natl Acad Sci USA. 114:E3334–E3343. 2017. View Article : Google Scholar : PubMed/NCBI
30	Lim JJ, Lima PDA, Salehi R, Lee DR and Tsang BK: Regulation of androgen receptor signaling by ubiquitination during folliculogenesis and its possible dysregulation in polycystic ovarian syndrome. Sci Rep. 7:102722017. View Article : Google Scholar : PubMed/NCBI
31	Albaghdadi AJH and Kan FWK: Immunosuppression with tacrolimus improved implantation and rescued expression of uterine progesterone receptor and its co-regulators FKBP52 and PIASy at nidation in the obese and diabetic mice: Comparative studies with metformin. Mol Cell Endocrinol. 460:73–84. 2018. View Article : Google Scholar